Supernus Pharmaceuticals | SUPN - EPS Earnings Per Share


Supernus Pharmaceuticals reported $-0.07 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24 2026
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04 2025
FY2025Q2 Jun/2025 0.40 0.46 0.77 Aug/05 2025
FY2025Q1 Mar/2025 -0.21 0.37 0.26 May/06 2025
FY2024Q4 Dec/2024 0.27 0.33 0.02 Feb/25 2025




Eps Change Date
Abbott USD 1.5 0.2 Dec/2025
ANI Pharmaceuticals USD 2.04 0.24 Sep/2025
Aurora Cannabis CAD -1 0.73 Sep/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025